BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6994483)

  • 41. Immunologic abnormalities in patients with malignant lymphoproliferative diseases.
    Hunter CP; Tannenbaum H; Churchill WH; Moloney WC; Schur PH
    J Natl Cancer Inst; 1977 May; 58(5):1185-90. PubMed ID: 323504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression.
    Küppers R; Rajewsky K; Hansmann ML
    Eur J Immunol; 1997 Jun; 27(6):1398-405. PubMed ID: 9209491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance of autorosette-forming cells in T-cell lymphoma.
    Tamura K; Aratake Y; Endo Y; Ohtaki S
    Leuk Res; 1984; 8(2):275-83. PubMed ID: 6609283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphocyte surface markers in lymphoproliferative disorders.
    Aiuti F; Lacava V; Fiorilli M; Ciarla MV
    Acta Haematol; 1973; 50(5):275-83. PubMed ID: 4202631
    [No Abstract]   [Full Text] [Related]  

  • 45. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathologic and immunologic characterization of malignant lymphoma in Taiwan. With special reference to retrovirus-associated adult T-cell lymphoma/leukemia.
    Su IJ; Shih LY; Kadin ME; Dun P; Hsu SM
    Am J Clin Pathol; 1985 Dec; 84(6):715-23. PubMed ID: 3000162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunologic phenotype in 30 patients with diffuse large-cell lymphoma.
    Warnke R; Miller R; Grogan T; Pederson M; Dilley J; Levy R
    N Engl J Med; 1980 Aug; 303(6):293-300. PubMed ID: 6770268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin's lymphomas.
    Jaffe ES; Strauchen JA; Berard CW
    Am J Clin Pathol; 1982 Jan; 77(1):46-9. PubMed ID: 7055097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-Hodgkin's lymphomas of the lung. A study of 19 cases emphasizing the utility of frozen section immunologic studies in differential diagnosis.
    Weiss LM; Yousem SA; Warnke RA
    Am J Surg Pathol; 1985 Jul; 9(7):480-90. PubMed ID: 3879107
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [IgG, IgA and IgM levels in Hodgkin's disease].
    Dziewulska-Bakiniec A; Piskorzyńska M
    Wiad Lek; 1981 Apr; 34(8):635-8. PubMed ID: 7303678
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cases of B cell lymphoma with polyclonal hypergammaglobulinemia and various autoantibodies].
    Nakano M; Kuwabara S; Kawanishi Y; Shiota M; Kimura Y; Toyama K
    Rinsho Ketsueki; 1988 Jan; 29(1):32-8. PubMed ID: 2838654
    [No Abstract]   [Full Text] [Related]  

  • 52. Malignant lymphoma with plasmacytoid differentiation and polyclonal gammopathy.
    Guardia J; Pedreira JD; Vidal MT; Roca A
    Acta Haematol; 1976; 55(6):346-53. PubMed ID: 820156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Malignant non-Hodgkin's lymphoma associated with a serum monoclonal immunoglobulin].
    Sotto JJ; Rueff A; Bensa JC; Sotto MF; Groslambert P; Favre M; Hollard D
    Presse Med; 1986 Mar; 15(12):569-73. PubMed ID: 2939407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Serum immunoglobulins in non-Hodgkin's lymphoma].
    Gola A; Nowicka J; Starzyk H; Niewolna M; Frydecka I
    Pol Tyg Lek; 1986 Mar; 41(13):417-9. PubMed ID: 3755239
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunological follow-up of non-Hodgkin's lymphoma (NHL) in children.
    Bogusławska-Jaworska J; Chybicka A; Pisarek J
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):733-8. PubMed ID: 6983870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
    Howard DR; Eaves AC; Takei F
    Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal immunoglobulins and autoantibodies in lymphoid malignancies.
    Katsikis PD; Pavlidis NA; Papadopoulos NM; Bai M; Moutsopoulos HM
    Anticancer Res; 1990; 10(6):1719-24. PubMed ID: 2285248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative analysis of IgG, IgA and IgM immunoglobulins in lymphatic leukemia and lymphosarcoma.
    Lawkowicz W; Kraj M; Cieśluk S
    Arch Immunol Ther Exp (Warsz); 1972; 20(2):227-34. PubMed ID: 4623511
    [No Abstract]   [Full Text] [Related]  

  • 59. [Serotonin and the immunologic reactivity of the body in taeniasis].
    Boroń-Kaczmarska A; Prokopowicz D; Rogowska D; Bobrowska E
    Angew Parasitol; 1987 Dec; 28(4):185-9. PubMed ID: 2451457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of two major B cell forms of nodular mixed lymphoma.
    Grogan TM; Hicks MJ; Jolley CS; Rangel CS; Jones SE
    Lab Invest; 1984 Nov; 51(5):504-14. PubMed ID: 6387274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.